CRMSB team took part in the Université de Bordeaux STS Scientific Day, where Valentine Michel presented some WP1 results from the ABCardionostics project.
Check out the full update on our website: abcardionostics.eu/abcardionost...
#EUproject #EICPathfinder #Atherosclerosis

Another partner contributing to ABCardionostics project: Bordeaux INP

They develop innovative purification methods for antibodies, ensuring quality for ABCardionostics imaging & therapy.
#BordeauxINP #ABCardionostics #EICPathfinder

Discover more: abcardionostics.eu/abcardionost...

#EUproject #EICPathfinder #ABCardionostics

The ABCardionostics consortium gathered in Maastricht on 6-7 Ocotber for its General Assembly, hosted by MUMC+.
A great opportunity to align, share progress, and strengthen collaboration!
#ABCardionostics #EICPathfinder #EUproject

CNIC drives the imaging front of ABCardionostics, pioneering a multi-marker PET/MRI approach and antibody labelling for advanced cardiovascular diagnostics.

#CNIC #ABCardionostics #EICPathfinder #EUproject

@cnrs.fr’s BacFly lab powers ABCardionostics with advanced antibody engineering, creating innovative bispecific antibodies for next-gen cardiovascular therapies.
#CNRS #BacFly #ABCardionostics #EICPathfinder #EUproject

Toulouse Biotechnology Institute drives ABCardionostics with cutting-edge biochip technology for high-throughput antibody target discovery and validation.
@inrae-france.bsky.social @cnrs.fr
#CNRS #INSA #INRAE #TBI #ABCardionostics #EICPathfinder

@univbordeaux.bsky.social coordinates ABCardionostics, with its CRMSB lab bringing top-tier expertise in phage display and antibody discovery to revolutionise cardiovascular care.
More info about the project: abcardionostics.eu
#ABCardionostics #EICPathfinder #EUproject

The ABCardionostics website is live!
We're tackling ASVD with biotech & imaging innovations.
🌐 abcardionostics.eu
#EUHealth #HorizonEU #EICPathfinder #ABCardionostics #CVD

On March 10th, the ABCardionostics consortium held its General Assembly meeting online! This important gathering brought together our partners to review progress, share results, and discuss the latest scientific and technical advancements.
#ABCardionostics #EICPathfinder

Cardiovascular diseases remain a leading global health challenge. Through biotechnology and advanced imaging, we are working to identify high-risk patients earlier and offer personalized therapies, paving the way for a new era in cardiovascular medicine.
#ABCardionostics #EICPathfinder